









Markets
/
Stocks
/
nasdaq-kavl
/

Kaival Brands Innovations Group Inc

KAVL



View Detailed Chart

0.136USD

0.000

Close 12/24, 13:00（ET）Quotes delayed by 15 min

1.57MMarket Cap

LossP/E TTM



Kaival Brands Innovations Group Inc

0.136

0.000

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Intraday

30m

Today

0.00%

5 Days

-6.34%

1 Month

-71.67%

6 Months

-74.81%

Year to Date

-85.11%

1 Year

-83.71%

View Detailed Chart

TradingKey Stock Score of Kaival Brands Innovations Group Inc

Currency: USD Updated: 2025-12-22

Key Insights

Kaival Brands Innovations Group Inc's fundamentals are relatively very healthy, and its growth potential is good.Its valuation is considered fairly valued, ranking 30/31 in the Food & Drug Retailing industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Kaival Brands Innovations Group Inc's Score

Industry at a Glance

Industry Ranking

30 / 31

Overall Ranking

488 / 4578

Industry

Food & Drug Retailing

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Kaival Brands Innovations Group Inc Highlights

StrengthsRisks

Kaival Brands Innovations Group, Inc. is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products, also known as e-cigarettes, in a variety of favors. The Company operates through an international licensing agreement with Philip Morris Products S.A. (PMPSA), a wholly owned affiliate of Philip Morris International Inc. (PMI). Its patent portfolio consists of approximately 19 existing and 47 pending with technologies related to vaporization and inhalation technologies. Its trademarks include KAIVAL BRANDS and KAIVAL LABS.

Growing

The company is in a growing phase, with the latest annual income totaling USD 6.89M.

Overvalued

The company’s latest PE is -0.23, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 172.92K shares, decreasing 25.24% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 51.44K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of -0.36.